Nielsen: Vape Sales Decline in U.S., Vuse Market Share Slightly Rising to 42.2%

Market by 2FIRSTS.ai

Mar.06.2024

Nielsen: Vape Sales Decline in U.S., Vuse Market Share Slightly Rising to 42.2%

According to Journalnow, e-cigarette sales in the US have dropped 13.9%, with Vuse by R.J. Reynolds gaining market share.

According to a recent report by Journalnow, data released by Nielsen Convenience Store shows that overall e-cigarette sales in the United States have decreased by 13.9%.

Among them, the market share of the best-selling e-cigarette brand Vuse, owned by British American Tobacco subsidiary R.J. Reynolds, has gradually increased from 42% to 42.2%; while the second-ranked JUUL's market share remains unchanged at 24.2%; the market share of NJoy, acquired by Ascent Industries, has reached 3.2%; and the market share of blu eCigs, owned by Imperial Tobacco subsidiary Fontem Ventures, has decreased from 1.2% to 1.1%.

In 2019, JUUL held a market share of 74.6% in the e-cigarette market in the United States. However, a series of regulatory actions have led to a reduction in product availability and a decrease in consumer demand.

British American Tobacco and Imperial Brands are urging the Food and Drug Administration (FDA) to crack down on the illegal synthetic nicotine e-cigarette products in the US tobacco market. The two companies estimate that these synthetic tobacco products account for half of the entire e-cigarette market in the United States.

The Nielsen report primarily focuses on large chain stores, while for small chain stores, the organization relies on trend extrapolation.

References:

[1] Shadow of illicit e-cigarette sales continues to grow over sector

Also Read:

[1] Recent Nielsen Data: Vuse and Juul Battle for Market Share

[2] Rapid Growth of E-Cigarettes in UK

[3] Vuse's Sales Rise Against Market Decline in Nielsen Report

[4] Reynolds Vuse E-Cigarette Market Share Increases, Juul Ranking 2rd

[5] VUSE Maintains Leading Position in Market Share, JUUL Declines

[6] Vuse E-cigarette's Market Share Drops Slightly but Remains on Top

#North America #United States #E-cigarettes #Open system e-cigarettes #Market #Disposable e-cigarettes #vuse #E-cigarette Market

We welcome news tips, article submissions, interview requests, or comments on this piece.

Please contact us at info@2firsts.com, or reach out to Alan Zhao, CEO of 2Firsts, on LinkedIn

Notice

1. This article is intended solely for professional research purposes related to industry, technology, and policy. Any references to brands or products are made purely for objective description and do not constitute any form of endorsement, recommendation, or promotion by 2Firsts.

2. The use of nicotine-containing products — including, but not limited to, cigarettes, e-cigarettes, nicotine pouchand heated tobacco products — carries significant health risks. Users are responsible for complying with all applicable laws and regulations in their respective jurisdictions.

3. This article is not intended to serve as the basis for any investment decisions or financial advice. 2Firsts assumes no direct or indirect liability for any inaccuracies or errors in the content.

4. Access to this article is strictly prohibited for individuals below the legal age in their jurisdiction.

Copyright

This article is either an original work created by 2Firsts or a reproduction from third-party sources with proper attribution. All copyrights and usage rights belong to 2Firsts or the original content provider. Unauthorized reproduction, distribution, or any other form of unauthorized use by any individual or organization is strictly prohibited. Violators will be held legally accountable.

For copyright-related inquiries, please contact: info@2firsts.com

AI Assistance Disclaimer

This article may have been enhanced using AI tools to improve translation and editorial efficiency. However, due to technical limitations, inaccuracies may occur. Readers are encouraged to refer to the cited sources for the most accurate information.

We welcome any corrections or feedback. Please contact us at: info@2firsts.com

Philip Morris Japan launches new IQOS SENTIA “Icy Red” flavor with icy menthol and red berry notes

Philip Morris Japan has announced the launch of a new SENTIA Icy Red tobacco stick for its IQOS ILUMA i and IQOS ILUMA heated tobacco devices, featuring an intense menthol profile with red fruit notes. The new product will roll out in stages from December across physical IQOS outlets, online channels and tobacco retailers nationwide in Japan, priced at 530 yen (approx. USD 3.4) per pack.

Dec.01 by 2FIRSTS.ai

Product | Up to 100,000 Puffs and Over 2,000 Puffs per ml: MASKKING, MR FOG, HYPERBAR Roll Out Ultra High-Puff New Devices

In 2025, disposable vapes are shifting from a “puff count race” to a focus on user experience. While 30,000–50,000 puffs has become mainstream, brands like MASKKING, MR FOG, and HYPERBAR are still launching higher-capacity products in the 60,000–100,000 puff range. Models with disclosed tank sizes all exceed 2,000 puffs per mL and commonly feature adjustable wattage and enhanced interactive functions.

Nov.14 by 2FIRSTS.ai

Scandinavian Tobacco Group Reports Q3 2025 Results and Narrows Full-Year Guidance

Scandinavian Tobacco Group (STG) reported net sales of DKK 2.4 billion for Q3 2025, in line with last year. EBITDA before special items reached DKK 519 million with a 22.0% margin. Handmade Cigars and Next Generation Products saw organic growth, while Machine-Rolled Cigars and Smoking Tobacco declined. The company narrowed its full-year guidance.

Nov.12 by 2FIRSTS.ai

AG Miyares Argues Vape Ban Consistent with Federal Law, Seeks Dismissal

Virginia Attorney General Jason Miyares and Tax Commissioner James J. Alex have asked a federal court to dismiss a lawsuit challenging the state’s ban on flavored e-cigarettes. They argue plaintiffs lack standing because the products are already illegal under federal law. The state denies claims of federal preemption and asserts sovereign immunity, maintaining that its ban aligns with its authority to protect public health.